RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Nektar Therapeutics Stock

Nektar Therapeutics Dividend 2024

Nektar Therapeutics Dividend

0 USD

Nektar Therapeutics Dividend yield

Ticker

NKTR

ISIN

US6402681083

WKN

165417

How much dividend does Nektar Therapeutics 2024 pay?

According to the latest status from September 2024, Nektar Therapeutics paid a total of 0 USD per share in dividends within the last 12 months. With the current Nektar Therapeutics price of 1.3 USD, this corresponds to a dividend yield of 0 %. A dividend is paid times per year.

=

Historical Nektar Therapeutics Dividends

A dividend is paid times per year. Last year, the payout months were and .

PaydateDividend

Is the Nektar Therapeutics Dividend Safe?

Nektar Therapeutics has been increasing the dividend for 0 years.

Over the past 10 years, Nektar Therapeutics has increased it by an annual 0 %.

Over a five-year period, the distribution increased by 0%.

Analysts expect a Dividend Cut of -100% for the current fiscal year.

Dividend Details

Understanding Nektar Therapeutics's Dividend Distributions

Nektar Therapeutics’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Nektar Therapeutics's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Nektar Therapeutics's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Nektar Therapeutics’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Nektar Therapeutics Aktienanalyse

What does Nektar Therapeutics do?

"Answer: Nektar Therapeutics is an American biopharmaceutical company based in San Francisco, specializing in the discovery and development of drugs for the treatment of cancer, autoimmune, and chronic metabolic diseases. The company was founded in 1990 by CEO Howard Robin and his team, initially focused on researching new technologies for drug development and later shifted to developing drugs for cancer therapy. Nektar Therapeutics has a unique business model that involves partnering with major pharmaceutical companies and other partners to develop a wide range of products, which are then licensed to these partners for commercialization and distribution. The company operates in several sectors, including oncology, pain management, autoimmune diseases, and metabolic diseases. Its important products include Movantik for opioid-induced constipation and ONZEALD for pancreatic cancer treatment. Nektar Therapeutics has made significant progress in developing immunoncology drugs, with potential projects such as NKTR-214 for advanced skin cancers. With its leading position in innovative drug development and strategic partnerships, the company has the potential to become a major player in cancer therapy." Nektar Therapeutics is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Nektar Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Frequently Asked Questions about Nektar Therapeutics stock

How much dividend does Nektar Therapeutics pay?

Over the past 12 months, Nektar Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Nektar Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Nektar Therapeutics?

The current dividend yield of Nektar Therapeutics is .

When does Nektar Therapeutics pay dividends?

Nektar Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Nektar Therapeutics?

Nektar Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Nektar Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Nektar Therapeutics located?

Nektar Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Nektar Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Nektar Therapeutics from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Nektar Therapeutics pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Nektar Therapeutics in the year 2023?

In the year 2023, Nektar Therapeutics distributed 0 USD as dividends.

In which currency does Nektar Therapeutics pay out the dividend?

The dividends of Nektar Therapeutics are distributed in USD.

Andere Kennzahlen von Nektar Therapeutics

Our stock analysis for Nektar Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nektar Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.